Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Vaccines

  Free Subscription


Articles published in Lancet

Retrieve available abstracts of 49 articles:
HTML format
Text format



Single Articles


    December 2017
  1. MASTERSON L, O'Mahony J, Lechner M
    Expanding the benefits of HPV vaccination to boys and men.
    Lancet. 2017;388:2992.
    PubMed     Text format    


    October 2017
  2. YIN Y
    HPV vaccination in China needs to be more cost-effective.
    Lancet. 2017;390:1735-1736.
    PubMed     Text format    


    September 2017
  3. JIN C, Gibani MM, Moore M, Juel HB, et al
    Efficacy and immunogenicity of a Vi-tetanus toxoid conjugate vaccine in the prevention of typhoid fever using a controlled human infection model of Salmonella Typhi: a randomised controlled, phase 2b trial.
    Lancet. 2017 Sep 28. pii: S0140-6736(17)32149.
    PubMed     Text format     Abstract available


  4. FEASEY NA, Levine MM
    Typhoid vaccine development with a human challenge model.
    Lancet. 2017 Sep 28. pii: S0140-6736(17)32407.
    PubMed     Text format    


  5. HUH WK, Joura EA, Giuliano AR, Iversen OE, et al
    Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16-26 years: a randomised, double-blind trial.
    Lancet. 2017 Sep 5. pii: S0140-6736(17)31821.
    PubMed     Text format     Abstract available


  6. DENNY L
    Nine-valent human papillomavirus vaccine: great science, but will it save lives?
    Lancet. 2017 Sep 5. pii: S0140-6736(17)32144.
    PubMed     Text format    


    July 2017
  7. HINMAN AR, Orenstein WA
    Collaborating to achieve Global Vaccine Action Plan goals.
    Lancet. 2017;390:451-452.
    PubMed     Text format    


  8. ALBERER M, Gnad-Vogt U, Hong HS, Mehr KT, et al
    Safety and immunogenicity of a mRNA rabies vaccine in healthy adults: an open-label, non-randomised, prospective, first-in-human phase 1 clinical trial.
    Lancet. 2017 Jul 25. pii: S0140-6736(17)31665.
    PubMed     Text format     Abstract available


  9. WARRELL M
    Is there a future for mRNAs as viral vaccines?
    Lancet. 2017 Jul 25. pii: S0140-6736(17)31964.
    PubMed     Text format    


  10. PETOUSIS-HARRIS H, Paynter J, Morgan J, Saxton P, et al
    Effectiveness of a group B outer membrane vesicle meningococcal vaccine against gonorrhoea in New Zealand: a retrospective case-control study.
    Lancet. 2017 Jul 7. pii: S0140-6736(17)31449.
    PubMed     Text format     Abstract available


  11. SEIB KL
    Gonorrhoea vaccines: a step in the right direction.
    Lancet. 2017 Jul 7. pii: S0140-6736(17)31605.
    PubMed     Text format    


    June 2017
  12. ROUPHAEL NG, Paine M, Mosley R, Henry S, et al
    The safety, immunogenicity, and acceptability of inactivated influenza vaccine delivered by microneedle patch (TIV-MNP 2015): a randomised, partly blinded, placebo-controlled, phase 1 trial.
    Lancet. 2017 Jun 27. pii: S0140-6736(17)30575.
    PubMed     Text format     Abstract available


  13. HOSCHLER K, Zambon MC
    Influenza vaccine: going through a sticky patch.
    Lancet. 2017 Jun 27. pii: S0140-6736(17)31364.
    PubMed     Text format    


  14. ZAROCOSTAS J
    Cholera outbreak in Haiti-from 2010 to today.
    Lancet. 2017;389:2274-2275.
    PubMed     Text format    


    March 2017
  15. THE LANCET
    Evaluating industry's role in vaccine access.
    Lancet. 2017;389:984.
    PubMed     Text format    


    February 2017
  16. CHAN M, Elias C, Fauci A, Lake A, et al
    Reaching everyone, everywhere with life-saving vaccines.
    Lancet. 2017;389:777-779.
    PubMed     Text format    


    January 2017
  17. CLINTON C, Sridhar D
    Who pays for cooperation in global health? A comparative analysis of WHO, the World Bank, the Global Fund to Fight HIV/AIDS, Tuberculosis and Malaria, and Gavi, the Vaccine Alliance.
    Lancet. 2017 Jan 27. pii: S0140-6736(16)32402.
    PubMed     Text format     Abstract available


    December 2016
  18. HENAO-RESTREPO AM, Camacho A, Longini IM, Watson CH, et al
    Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ca Suffit!).
    Lancet. 2016 Dec 23. pii: S0140-6736(16)32621.
    PubMed     Text format     Abstract available


  19. GROBUSCH MP, Goorhuis A
    Safety and immunogenicity of a recombinant adenovirus vector-based Ebola vaccine.
    Lancet. 2016 Dec 22. pii: S0140-6736(16)32619.
    PubMed     Text format    


  20. GEISBERT TW
    First Ebola virus vaccine to protect human beings?
    Lancet. 2016 Dec 22. pii: S0140-6736(16)32618.
    PubMed     Text format    


  21. ZHU FC, Wurie AH, Hou LH, Liang Q, et al
    Safety and immunogenicity of a recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in Sierra Leone: a single-centre, randomised, double-blind, placebo-controlled, phase 2 trial.
    Lancet. 2016 Dec 22. pii: S0140-6736(16)32617.
    PubMed     Text format     Abstract available


  22. PARIKH SR, Andrews NJ, Beebeejaun K, Campbell H, et al
    Effectiveness and impact of a reduced infant schedule of 4CMenB vaccine against group B meningococcal disease in England: a national observational cohort study.
    Lancet. 2016;388:2775-2782.
    PubMed     Text format     Abstract available


  23. BASTA NE, Christensen H
    4CMenB vaccine effectiveness: reasons for optimism.
    Lancet. 2016;388:2719-2721.
    PubMed     Text format    


    November 2016
  24. ASTURIAS EJ, Bandyopadhyay AS, Clemens R, Orenstein W, et al
    New poliovirus vaccine schedules - Authors' reply.
    Lancet. 2016;388:2478.
    PubMed     Text format    


  25. ZHANG Q, Leppold C, Shao Y, Mura Y, et al
    New poliovirus vaccine schedules.
    Lancet. 2016;388:2477-2478.
    PubMed     Text format    


  26. THE LANCET
    Measles vaccination: global progress, local challenges.
    Lancet. 2016;388:2450.
    PubMed     Text format    


  27. WU JT, Peak CM, Leung GM, Lipsitch M, et al
    Fractional dosing of yellow fever vaccine to extend supply: a modelling study.
    Lancet. 2016 Nov 9. pii: S0140-6736(16)31838.
    PubMed     Text format     Abstract available


    October 2016
  28. HALSTEAD SB, Aguiar M
    Is discussion of dengue vaccination for the 2016 Olympics necessary?: Authors' reply.
    Lancet. 2016;388:1881-1882.
    PubMed     Text format    


  29. SCHWARZ TF
    Is discussion of dengue vaccination for the 2016 Olympics necessary?
    Lancet. 2016;388:1881.
    PubMed     Text format    


  30. ARREDONDO-GARCIA JL, Hadinegoro SR, Guy B, Bouckenooghe A, et al
    Is discussion of dengue vaccination for the 2016 Olympics necessary?
    Lancet. 2016;388:1880-1881.
    PubMed     Text format    


  31. WANG LD, Lam WW, Fielding R
    Parental decision-making with regards to vaccination against human papilloma virus in adolescent girls in Hong Kong, China: a prospective cohort study.
    Lancet. 2016;388 Suppl 1:S78.
    PubMed     Text format     Abstract available


    September 2016
  32. AKANMORI BD, Mukanga DO, Mihigo R, Ward M, et al
    New development of medicines for priority diseases in Africa.
    Lancet. 2016;388:1053-4.
    PubMed     Text format    


  33. ELACHOLA H, Ditekemena J, Zhuo J, Gozzer E, et al
    Yellow fever outbreaks, vaccine shortages and the Hajj and Olympics: call for global vigilance.
    Lancet. 2016 Sep 5. pii: S0140-6736(16)31546.
    PubMed     Text format    


    August 2016
  34. DOIRON PR, Bunker CB
    Expanding the benefits of HPV vaccination to boys and men.
    Lancet. 2016;388:659.
    PubMed     Text format    


    July 2016
  35. THE LANCET
    HPV vaccination: a decade on.
    Lancet. 2016;388:438.
    PubMed     Text format    


  36. MAURICE J
    The Zika virus public health emergency: 6 months on.
    Lancet. 2016;388:449-50.
    PubMed     Text format    


  37. HALSTEAD SB, Aguiar M
    Dengue vaccine and the 2016 Olympics.
    Lancet. 2016;388:237-8.
    PubMed     Text format    


    June 2016
  38. GREEN A
    Yellow fever continues to spread in Angola.
    Lancet. 2016;387:2493.
    PubMed     Text format    


  39. MAYER KH, Shisana O, Beyrer C
    AIDS 2016: from aspiration to implementation.
    Lancet. 2016;387:2484-5.
    PubMed     Text format    


  40. QIU J, Hu H, Zhou S, Liu Q, et al
    Vaccine scandal and crisis in public confidence in China.
    Lancet. 2016;387:2382.
    PubMed     Text format    


  41. MCGILL F, Heyderman RS, Panagiotou S, Tunkel AR, et al
    Acute bacterial meningitis in adults.
    Lancet. 2016 Jun 2. pii: S0140-6736(16)30654.
    PubMed     Text format     Abstract available


    May 2016
  42. CHAN M
    Yellow fever: the resurgence of a forgotten disease.
    Lancet. 2016;387:2165-6.
    PubMed     Text format    


  43. ASTURIAS EJ, Bandyopadhyay AS, Self S, Rivera L, et al
    Humoral and intestinal immunity induced by new schedules of bivalent oral poliovirus vaccine and one or two doses of inactivated poliovirus vaccine in Latin American infants: an open-label randomised controlled trial.
    Lancet. 2016 May 19. pii: S0140-6736(16)00703.
    PubMed     Text format     Abstract available


  44. PARKER EP, Grassly NC
    Polio vaccination: preparing for a change of routine.
    Lancet. 2016 May 19. pii: S0140-6736(16)30593.
    PubMed     Text format    


  45. O'BRIEN KL, Binka F, Marsh K, Abramson JS, et al
    Mind the gap: jumping from vaccine licensure to routine use.
    Lancet. 2016;387:1887-9.
    PubMed     Text format    


    April 2016
  46. SCHMELER KM, Sturgis EM
    Expanding the benefits of HPV vaccination to boys and men.
    Lancet. 2016;387:1798-9.
    PubMed     Text format    


  47. LOCARNINI S, Chen DS, Shibuya K
    No more excuses: viral hepatitis can be eliminated.
    Lancet. 2016;387:1703-4.
    PubMed     Text format    



  48. Yellow fever: a global reckoning.
    Lancet. 2016;387:1348.
    PubMed     Text format    


    February 2016
  49. WILLISON HJ, Jacobs BC, van Doorn PA
    Guillain-Barre syndrome.
    Lancet. 2016 Feb 29. pii: S0140-6736(16)00339.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Vaccines is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: